Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.First Amendment to Asset Purchase Agreement • June 12th, 2018 • Translate Bio, Inc. • Biological products, (no disgnostic substances)
Reference is made to the Asset Purchase Agreement by and between Translate Bio, Inc. formerly known as RaNA Therapeutics, Inc. (“Translate Bio”) and Shire Human Genetics Therapies, Inc. (“Shire”) entered into as of December 22, 2016 (the “Agreement”). Capitalized terms used but not defined herein have the respective meanings set forth in the Agreement.
